TRLV · NYSE
Trulieve Cannabis (TRLV) Stock Price & Fundamentals
Trulieve Cannabis (TRLV) closed at $543.02 on Oct 9, 2026, down 0.37% from the previous close of $545.05.
Share price, past year
1Y +59.80%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $543.02 |
| Sep 30, 2026 | $546.37 |
| Aug 31, 2026 | $505.50 |
| Jul 31, 2026 | $498.12 |
| Jun 30, 2026 | $483.96 |
| May 29, 2026 | $449.98 |
| Apr 30, 2026 | $442.52 |
| Mar 31, 2026 | $416.52 |
| Feb 27, 2026 | $413.39 |
| Jan 30, 2026 | $389.97 |
| Dec 31, 2025 | $366.27 |
| Nov 28, 2025 | $346.64 |
| Oct 31, 2025 | $327.34 |
Key statistics
- Market cap
- $104.47B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $1.14B
- Net income (TTM)
- —
- Shares outstanding
- 192.4M
- Dividend yield
- —
- 52-week range
- $326.45 – $554.24
Trulieve Cannabis's market cap is $104.47B, based on a share price of $543.02 and 192.4M shares outstanding as of Jun 30, 2026.
Financials
Trulieve Cannabis reported revenue of $1.18B for fiscal 2025, down 0.45% from fiscal 2024.
Trulieve Cannabis reported a net loss of $252.73M in fiscal 2022.
Trulieve Cannabis's fiscal 2022 net loss was its first in at least 3 years.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.18B | −0.5% | — | — | −$0.58 | $228.63M |
| FY2024ended Dec 31, 2024 | $1.19B | +5.1% | — | — | −$0.79 | $148.88M |
| FY2023ended Dec 31, 2023 | $1.13B | −7.3% | — | — | −$2.28 | $161.60M |
| FY2022ended Dec 31, 2022 | $1.22B | +30.7% | −$252.73M | −20.8% | −$0.95 | −$141.65M |
| FY2021ended Dec 31, 2021 | $931.93M | +78.7% | $17.45M | 1.9% | $0.21 | −$263.00M |
| FY2020ended Dec 31, 2020 | $521.53M | +106.3% | $63.00M | 12.1% | $0.53 | −$298.00K |
| FY2019ended Dec 31, 2019 | $252.82M | — | $53.10M | 21.0% | $0.46 | −$52.76M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $270.95M | — | — |
| Q1 FY2026ended Mar 31, 2026 | $286.75M | — | — |
| Q4 FY2025ended Dec 31, 2025 | $293.15M | — | — |
| Q3 FY2025ended Sep 30, 2025 | $288.19M | — | — |
| Q2 FY2025ended Jun 30, 2025 | $302.09M | — | — |
| Q1 FY2025ended Mar 31, 2025 | $297.76M | — | −$0.16 |
| Q4 FY2024ended Dec 31, 2024 | $301.15M | — | −$0.27 |
| Q3 FY2024ended Sep 30, 2024 | $284.28M | −$61.60M | −$0.32 |
Company profile
- Name
- Trulieve Cannabis Corp.
- Ticker
- TRLV
- Exchange
- NYSE
- Industry (SEC SIC)
- Medicinal Chemicals & Botanical Products
- Headquarters
- 3494 Martin Hurst Road, Tallahassee, FL 32312
- Incorporated in
- A1
- Fiscal year ends
- December
- SEC CIK
- 0001754195
Recent SEC filings
- Aug 11, 2026
- Aug 7, 2026
- Aug 7, 2026
- Aug 5, 2026
- Jul 2, 2026
- Jun 12, 2026
- Jun 11, 2026
- Jun 9, 2026
Frequently asked questions
What is Trulieve Cannabis's stock price?
Trulieve Cannabis (TRLV) closed at $543.02 on Oct 9, 2026, down 0.37% from the previous close of $545.05.
What is Trulieve Cannabis's market cap?
Trulieve Cannabis's market cap is $104.47B, based on a share price of $543.02 and 192.4M shares outstanding as of Jun 30, 2026.
How much revenue does Trulieve Cannabis make?
Trulieve Cannabis reported revenue of $1.18B for fiscal 2025, down 0.45% from fiscal 2024.
Does Trulieve Cannabis pay a dividend?
Trulieve Cannabis's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Trulieve Cannabis Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures